drugset / Trial / NCT06996886
A Study in Healthy Participants to Investigate Relative Bioavailability of AZD5004 in Three Solid Oral Formulations
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to assess the relative bioavailability of a single dose AZD5004 in healthy participants, among 3 different oral tablet formulations.
Timeline
- Start
- 2025-05-22
- Primary completion
- 2025-07-15
- Completion
- 2025-07-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD5004 | Unknown | — | Oral |
Indications
No indication recorded.